Brief: Quantum Genomics initiates phase IIa trial for heart failure

Quantum Genomics SA

30/06/2016 17:04

June 30 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Opening of the first hospital centres in france and 
norway, and the beginning of the phase iia study in heart 
failure 
    * First clinical centres have been initiated at Louis Pradel 
Hospital in Lyon (France), Stavanger University Hospital in 
Stavanger (Norway) and Laennec Hospital in Nantes (France) 
 
Source text for Eikon:  ID:nACT44791  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))